AtaiBeckley (ATAI) Research & Development (2020 - 2026)

AtaiBeckley's (ATAI) quarterly Research & Development came in at $17.4 million in Q1 2026, up 53.73% year-on-year from $11.3 million in Q1 2025, and up 53.73% quarter-over-quarter from $11.3 million in Q1 2025.

AtaiBeckley (ATAI) Research & Development (2020 - 2026) Analysis & Trends

AtaiBeckley (ATAI) has 6 years of Research & Development data on file, last reported at $14.7 million in Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 18.61% year-over-year to $14.7 million; the trailing twelve-month figure through Sep 2025 stood at $56.0 million (up 687.75% YoY), and the FY2024 full-year result was $55.5 million, up 2672.75% from the prior year.
  • Research & Development rose to $17.4 million in Q1 2026 per ATAI's latest filing, from $11.3 million in the prior quarter.
  • Across five years, Research & Development topped out at $17.4 million in Q1 2026 and bottomed at $11.3 million in Q1 2025.
  • A 5-year average of $7.6 million and a median of $13.3 million in 2023 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development jumped 461.53% in 2021 and slumped 482.35% in 2022, its largest moves.
  • Tracing ATAI's Research & Development over 5 years: stood at $13.0 million in 2021, then tumbled by 482.35% to -$49.6 million in 2022, then increased by 7.23% to -$46.0 million in 2023, then jumped by 141.14% to $18.9 million in 2024, then decreased by 22.5% to $14.7 million in 2025.
  • Business Quant data shows ATAI's Research & Development at $14.7 million in Q3 2025, $11.1 million in Q2 2025, and $11.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -17.94 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 541.22 Mn
4 NuCana 279.75 Bn 279.75 Bn - -2.31 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.66 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.37 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 343.97 Mn
10 AtaiBeckley 2.56 Bn 2.56 Bn - 14.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 17.41 Mn
Sep 30, 2025 14.68 Mn
Jun 30, 2025 11.09 Mn
Mar 31, 2025 11.33 Mn
Mar 31, 2025 11.33 Mn
Dec 31, 2024 18.94 Mn
Sep 30, 2024 12.38 Mn
Jun 30, 2024 12.61 Mn
Mar 31, 2024 11.53 Mn
Dec 31, 2023 -46.05 Mn
Sep 30, 2023 13.29 Mn
Jun 30, 2023 15.48 Mn
Mar 31, 2023 19.28 Mn
Dec 31, 2022 -49.64 Mn
Sep 30, 2022 19.03 Mn
Jun 30, 2022 17.95 Mn
Mar 31, 2022 15.46 Mn
Dec 31, 2021 12.98 Mn
Sep 30, 2021 13.36 Mn
Jun 30, 2021 16.03 Mn